1-151428046-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015100.4(POGZ):c.860-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000347 in 1,614,014 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_015100.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POGZ | NM_015100.4 | c.860-5C>T | splice_region_variant, intron_variant | ENST00000271715.7 | NP_055915.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POGZ | ENST00000271715.7 | c.860-5C>T | splice_region_variant, intron_variant | 1 | NM_015100.4 | ENSP00000271715.2 |
Frequencies
GnomAD3 genomes AF: 0.00191 AC: 290AN: 152184Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000482 AC: 121AN: 250908Hom.: 0 AF XY: 0.000413 AC XY: 56AN XY: 135660
GnomAD4 exome AF: 0.000185 AC: 271AN: 1461712Hom.: 0 Cov.: 32 AF XY: 0.000171 AC XY: 124AN XY: 727156
GnomAD4 genome AF: 0.00190 AC: 289AN: 152302Hom.: 1 Cov.: 31 AF XY: 0.00176 AC XY: 131AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2019 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at